Basch appointed to NCI Board of Scientific Advisors
“I am enthusiastic to serve in this role at the NCI, particularly at this time when research in cancer control, health outcomes, and policy is needed to produce the best care -- as the U.S. system comes under increasing strain related to cost and quality. The NCI’s research portfolio has been a vital component to advancing science in these areas,” said Basch.
The BSA evaluates and makes recommendations on research priorities, grant programs and cooperative agreements of the NCI. Dr. Basch is a medical oncologist and health services researcher whose research focuses on patient-reported outcomes, comparative effectiveness research and drug regulatory policy. The UNC Lineberger Cancer Outcomes Research Program is an interdisciplinary program supporting the work of UNC investigators across the Health Affairs Schools and the College analyzing and improving cancer health services and outcomes.
“Dr. Basch is a superb oncologist with outstanding health services research skills particularly in the area of patient reported outcomes. His work is truly germane to the patient experience and improving cancer outcome. At this time of national health care reform that will alter how we care for cancer patients, it is crucial that NCI get top-flight advice from people like Dr. Basch,” said Shelley Earp, MD, Director of UNC Lineberger.